French Business Law - French Legislation

Article R1211-17 of the French Public Health Code

November 5, 2023

An order of the Minister for Health sets out : 1° The nature of and conditions for carrying out medical biology tests to detect infection markers; 2° Where technically possible, the nature and conditions for carrying out medical biology analyses to detect infectivity markers; 3° The nature of the analysis consisting of searching for the virus genome; 4° The procedures for using the results of the analyses defined in this…

Article R1211-18 of the French Public Health Code

November 5, 2023

One or more samples of the biological product used to carry out the medical biology analyses provided for in articles R. 1211-14 to R. 1211-16 are kept under conditions set by order of the Minister for Health.

Article R1211-19 of the French Public Health Code

November 5, 2023

I.-In order to be used for therapeutic purposes, any element or product of the human body removed or collected must be accompanied by information relating in particular to the clinical and biological selection of donors, labelling and traceability of the element or product, the content of which is specified by order of the Minister for Health. II – The user doctor or dental surgeon is obliged to take note of…

Article R1211-19-1 of the French Public Health Code

November 5, 2023

I. – The purpose of traceability of elements and products of the human body is to establish the link between the donor and the recipient, from the time of removal to the time of therapeutic use or destruction, and vice versa. This traceability is established : 1° By information, the nature and content of which are laid down by order of the Minister for Health; 2° And, as far as…

Article R1211-20 of the French Public Health Code

November 5, 2023

When the nature of the element or product of the human body removed or collected and the uses envisaged for it allow this without impairing the effectiveness of these uses, treatments, in particular physical or chemical treatments, to eliminate or inactivate infectious agents that reduce the risks of transmission are carried out.

Article R1211-21 of the French Public Health Code

November 5, 2023

The doctor may waive the prohibition mentioned in the first paragraph of article R. 1211-14 when, despite the risk of transmission of a virus by the donor, the therapeutic alternatives to the transplant or to the use of human body products for therapeutic purposes are inappropriate and the prognosis is life-threatening. An order of the Minister for Health specifies the cases in which, despite the risk of transmission of a…

Article R1211-22 of the French Public Health Code

November 5, 2023

In situations of vital urgency and in the absence of therapeutic alternatives, the doctor may also waive the prohibition mentioned in the first paragraph of article R. 1211-14. An order by the Minister for Health specifies the cases in which, despite the risk of transmission of a virus by the donor, the graft or the use of products of the human body for therapeutic purposes may take place in the…

Article R1211-22-1 of the French Public Health Code

November 5, 2023

When the samples referred to in the first paragraph of article R. 1211-12 are taken for autologous administration and concern elements or products of the human body intended to be prepared or preserved, tests to detect infectious diseases are carried out. The list of these diseases and the conditions under which these tests are carried out are laid down by order of the Minister for Health.

Article R1211-22-2 of the French Public Health Code

November 5, 2023

In order to be used for autologous therapeutic purposes, any element or product of the human body removed or collected must be accompanied by a document containing an analysis report signed by the person responsible for the analyses performed, mentioning the individual results of these analyses in accordance with article R. 1211-22-1. This report also mentions the laboratory that performed the analyses. It is produced in the original, by fax…

Article R1211-25 of the French Public Health Code

November 5, 2023

The practitioner meeting the criteria mentioned in articles R. 2142-10 and R. 2142-11 carrying out sperm collection or oocyte retrieval with a view to donation is required : 1° Enquire about the gamete donor’s personal and family history and the clinical data he considers necessary to collect. If necessary, he will arrange for any additional examinations that he deems useful, in particular if the donor has been exposed in an…

Call Us + 33 1 84 88 31 00

Call Us + 33 1 84 88 31 00

Regulatory part

Article R1211-17 of the French Public Health Code

Article R1211-18 of the French Public Health Code

Article R1211-19 of the French Public Health Code

Article R1211-19-1 of the French Public Health Code

Article R1211-20 of the French Public Health Code

Article R1211-21 of the French Public Health Code

Article R1211-22 of the French Public Health Code

Article R1211-22-1 of the French Public Health Code

Article R1211-22-2 of the French Public Health Code

Article R1211-25 of the French Public Health Code

Contact a French lawyer now

Contact a French Business Lawyer

Do you need French-law advice?
Contact our Lawyers in France.

Call + 33 1 84 88 31 00.

Our attorneys will contact you promptly within 24h. All information exchanged through this website will be communicated to attorneys only, and will remain confidential.

We Solve Legal & Tax Issues in France

Regulatory part

Contact a French lawyer now

Contact a French Business Lawyer

Do you need French-law advice? Contact our Lawyers in France.

Our attorneys will contact you promptly within 24h. All information exchanged through this website will be communicated to attorneys only, and will remain confidential.

We Solve Legal & Tax Issues in France

Useful links

You have a question in French Business Law?

Do you need French-law advice?
Contact our Lawyers in France.